AbbVie Inc. - Depositary Receipt (ABBV)
BCBA
43,760.00
+720.00 (+1.67%)
Closed
Oct 7, 2026
Day's Range
43,600.0044,260.00
52 wk Range
28,420.0044,260.00
Financial Statements - ABBV - AbbVie Inc. - Depositary Receipt
Revenue
61.16B▼ 99.9%
Net Income
4.23B▼ 99.9%Net Margin 6.9%
EBITDA
22.70B▼ 99.9%
Free Cash Flow
17.81B▼ 99.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 61.16B | 81.55T | 54.31B | 58.05B | 56.19B | 45.80B |
| Cost of Goods | 18.20B | 24.47T | 20.41B | 17.41B | 17.44B | 15.38B |
| Gross Profit | 42.95B | 57.08T | 33.90B | 40.64B | 38.75B | 30.41B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 20.09B | 17.21T | 12.75B | 18.11B | 17.92B | 11.36B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -10.86B | -8.71T | -4.82B | -2.59B | -2.55B | -5.68B |
| Pre Tax Income | 6.59B | 5.37T | 6.25B | 13.47B | 12.98B | 3.39B |
| Income Tax | 2.36B | -825.21B | 1.37B | 1.63B | 1.44B | -1.22B |
| Net Income | 4.23B | 6.20T | 4.87B | 11.84B | 11.54B | 4.62B |
| EPS Basic | 2.37 | 2.423443 | 2.73 | 6.6901 | 6.527034 | 2.615101 |
| EPS Diluted | 2.37 | 2.39 | 2.72 | 6.63 | 6.45 | 2.615101 |
| Basic Shares Outstanding | 1.76B | 2.55T | 1.67M | 1.67M | 1.67M | 1.67M |
| Diluted Shares Outstanding | 1.76B | 2.55T | 1.67M | 1.67M | 1.67M | 1.67M |
| Ebit | 9.49B | 9.44T | 8.47B | 15.70B | 15.41B | 5.85B |
| Ebitda | 22.70B | 25.60T | 17.31B | 24.32B | 23.98B | 12.39B |
| Net Income Continuous Operations | 4.23B | 6.20T | 4.87B | 11.84B | 11.54B | 4.62B |
| Minority Interests | -7M | -8M | -10M | -9M | -7M | -6M |
| Preferred Stock Dividends | 40M | 57.91B | 43M | 54M | 74M | 60M |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
